SARS-CoV-2 Infection, Hospitalization, and Associated Factors Among People Living With HIV in Southeastern China From December 2022 to February 2023: Cross-Sectional Survey

• DOI: 10.2196/51449
• Publication Date: 2024-04-17T15:01:13Z
• Authors: Wei Cheng; Yun Xu; Haibo Jiang; Jun Li; Zhigang Hou; Haibin Meng; Wei Wang; Chengliang Chai; Jianmin Jiang
• Keywords: Cross-sectional study

Background Limited studies have explored the impact of Omicron variant on SARS-CoV-2 infection, hospitalization, and associated factors among people living with HIV, particularly in China. The adjustment preventive policies since December 2022 China presents an opportunity to evaluate real-world influencing infection related hospitalization HIV. Objective This study aimed investigate rates, HIV following from February 2023 southeastern Methods A cross-sectional telephone or web-based survey was conducted 5 cities 2023. Demographic information, HIV-specific characteristics were collected existing databases special investigations. Multivariate logistic regression analyses determine for rates SARS-CoV-2. Additionally, subgroup association between vaccination across different statuses time last vaccination. Results Among a COVID-19 testing history, rate 67.13% (95% CI 65.81%-68.13%), whereas 0.71% 0.46%-0.97%). Factors such as age, latest CD4 cell count, viral load, transmission route found be while cancer, load hospitalization. In terms vaccination, compared unvaccinated there lower those who had been vaccinated <3 months booster group (adjusted odds ratio [aOR] 0.72, 95% 0.53-0.98; P=.04); also risk received past 6-12 (aOR 0.33, 0.14-0.81; P=.02) more than 12 ago 0.22, 0.07-0.72; P=.01). Conclusions After ease prevention control measures China, we observed high but low rate. General factors, higher age status, HIV-related parameters, count campaign doses should considered confronting possible epidemic emergencies near future.